We are live on ! Find out more
TMCI icon

Treace Medical Concepts
TMCI

138 hedge funds and large institutions have $315M invested in Treace Medical Concepts in 2025 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 41 increasing their positions, 46 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,452% more call options, than puts

Call options by funds: $388K | Put options by funds: $25K

16% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 25

14% more capital invested

Capital invested by funds: $278M → $315M (+$37.5M)

2% more funds holding

Funds holding: 135 → 138 (+3)

0.7% more ownership

Funds ownership: 59.88% → 60.58% (+0.7%)

11% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 46

Holders
138
Holders Change
+3
Holders Change %
+2.22%
% of All Funds
1.85%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
29
Increased
41
Reduced
46
Closed
25
Calls
$388K
Puts
$25K
Net Calls
+$363K
Net Calls Change
-$704K

Top Buyers

Rank Fund Capital Flow
1
PHP
Parkman Healthcare Partners
Connecticut
+$6.41M
2
First Eagle Investment Management
First Eagle Investment Management
New York
+$4.48M
3
DCM
Driehaus Capital Management
Illinois
+$4.21M
4
CIBC Private Wealth Group
CIBC Private Wealth Group
Georgia
+$3.64M
5
SSA
Schonfeld Strategic Advisors
New York
+$3.47M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$5.48M
2
UBS Group
UBS Group
Switzerland
-$5.46M
3
N
Nuveen
North Carolina
-$1.98M
4
Goldman Sachs
Goldman Sachs
New York
-$1.84M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.76M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
151
Bayesian Capital Management
New York
– -$77.4K -10,403 Closed
DTL
152
Dynamic Technology Lab
Singapore
– -$77K -10,221 Closed
QL
153
Quarry LP
New York
– -$38.2K -5,131 Closed
PAS
154
Point72 Asia (Singapore)
Singapore
– -$27.1K -3,637 Closed
RS
155
R Squared
Hong Kong
– -$23.6K -3,170 Closed
PD
156
Point72 (DIFC)
United Arab Emirates
– -$20.5K -2,750 Closed
HI
157
Human Investing
Oregon
– -$12.4K -1,671 Closed
SO
158
STRS Ohio
Ohio
– -$11.9K -1,600 Closed
CAM
159
Creekmur Asset Management
Illinois
– -$1.81K -244 Closed
BIG
160
Brooklyn Investment Group
New York
– -$789 -106 Closed
AWM
161
Avior Wealth Management
Nebraska
– -$178 -24 Closed
C
162
Covestor
United Kingdom
– -$54 -6 -35%
IA
163
IFP Advisors
Florida
– -$15 -2 Closed
3 4 5 6
7

TMCI Hedge Fund Activity: Q1 2025 in Review

138 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q1 2025, worth a combined $315M — up 14% from $278M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new TMCI positions and 25 closed out — a net gain of 4 holders — while 41 added to existing stakes and 46 trimmed.

The largest buyer was Parkman Healthcare Partners, opening a new position worth an estimated $6.41M. The largest seller was Morgan Stanley, cutting an estimated $5.48M.

  • 138 institutional investors held Treace Medical Concepts (TMCI) as of Q1 2025, up from 135 in Q4 2024.
  • Funds reported $315M of Treace Medical Concepts stock for Q1 2025, up 14% quarter-over-quarter.
  • 29 funds opened new Treace Medical Concepts positions in Q1 2025 and 25 closed out, a net change of +4 holders.
  • The largest Treace Medical Concepts buyer in Q1 2025 was Parkman Healthcare Partners, an estimated $6.41M added.
  • The largest Treace Medical Concepts seller in Q1 2025 was Morgan Stanley, an estimated $5.48M sold.

Based on aggregated 13F filings for Q1 2025.